Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome

OBJECTIVES: The current standard of care for patients with metastatic prostate cancer (mPCa) at diagnosis is androgen deprivation therapy (ADT) with or without anti-androgen and chemotherapy. The aim of this study was to define the role of a local radiotherapy (RT) treatment in the mPCa setting. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Giulia, Marvaso, Giulia, Augugliaro, Matteo, Zerini, Dario, Fodor, Cristiana, Musi, Gennaro, De Cobelli, Ottavio, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718249/
https://www.ncbi.nlm.nih.gov/pubmed/29225693
http://dx.doi.org/10.3332/ecancer.2017.786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718249/
https://www.ncbi.nlm.nih.gov/pubmed/29225693
http://dx.doi.org/10.3332/ecancer.2017.786

Ejemplares similares